News
- December 14, 2012 | Journal of Hepatology
Hepatitis C infection and presence of advanced fibrosis: Wait or treat? Why wait? There is no time to lose, is there?
The author discusses some of the ethical challenges in treatment of hepatitis C infected patients with advanced fibrosis.
Read Article > - December 13, 2012 | Hepatology
Hepatitis C screening — getting it right
The USPSTF recently released a draft opinion on the recommendation of a one-time hepatitis C test for all baby boomers in the US. The article examines the Task Force’s internal process for writing its guidelines and makes recommendations.
Read Article > - December 10, 2012 | General Hospital Pscychiatry
Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations
Very few hepatitis C patients are receiving the treatment they need according to a review of 25 different studies with data on course of treatment and barriers to treatment.
Read Abract > - December 07, 2012 | Antiviral Therapy
Antibody- and genome-based identification of recent HCV infection
Discriminating between recent and persistent HCV infection may be accomplished by clinical markers in blood and genetics.
Read Article > - December 07, 2012 | Antiviral Therapy
Application of mass spectrometry to molecular surveillance of hepatitis B and C viral infections
Mass spectrometry is a new, inexpensive and reliable approach for molecular surveillance of hepatitis B and C infections.
Read Article > - December 07, 2012 | Antiviral Therapy
Molecular surveillance of hepatitis
The next-generation sequencing and mass spectrometry methods offer better accuracy in hepatitis C surveillance, which will be useful to track interferon resistant virulent infections.
Read Article > - December 07, 2012 | Antiviral Therapy
Rapid diagnostic HCV antibody assays
A survey of pre-market rapid anti-HCV yielded varied results.
Read Article > - December 07, 2012 | Antiviral Therapy
Changing strategies for hepatitis C testing
In this editorial by CDC Branch Chief Dr. Chong-Gee Teo, the importance of minimizing the complexity and costs associated with hepatitis C testing is discussed.
Read Article > - December 07, 2012 | Antiviral Therapy
Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals.
Major initiatives of wider hepatitis C testing and promoting linkage to treatment for those found to be infected are the development of tests of identifying recent and active infections.
Read Article > - December 07, 2012 | Antiviral Therapy
Testing and reporting practices for improved management of hepatitis C
Patients with hepatitis C have experienced recent improvements in treatment and disease management. These gains will be fully realized once surveillance of new cases is improved and reporting standards are harmonized.
Read Article >